Meta Information
ID:glucosamine-chondroitin
Name:Glucosamine and Chondroitin
Schema Version:1.5
Alternate Names
- Glucosamine Sulfate
- Chondroitin Sulfate
Active Compound
glucosamine sulfate, chondroitin sulfate
Intervention Type
synergistic_therapy
Delivery
Route:
oral
Scope:
- systemic
Regulatory Status
- us:dietary_supplement
- eu:food_supplement
Indication
Focus:
symptom_management
Description:
Management of symptoms associated with osteoarthritis, particularly joint pain and stiffness.
Typical Protocol
- Commonly dosed at 1500 mg/day for glucosamine and 1200 mg/day for chondroitin, often taken together.
Expected Cost Mean
Low Cost:
10
High Cost:
40
Cost Type:
monthly
Description:
Monthly cost for common over-the-counter supplement, typically not insurance-covered.
Summary
Glucosamine and chondroitin are natural components of cartilage. As supplements, they are proposed to support cartilage structure and reduce joint pain and stiffness in osteoarthritis by providing building blocks for cartilage repair and potentially anti-inflammatory effects. Evidence for direct healthspan extension is lacking.
Purpose
Supports joint health, manages osteoarthritis symptoms; not a direct healthspan intervention.
Card Summary
Supports joint health and manages osteoarthritis symptoms.
Drug Class
null
Drugs In Class
Empty Array
Impact
Score:
4.5
Justification:
Specific benefit for joint health, limited systemic healthspan impact.
Evidence
Grade:
B
Score:
5.5
Justification:
Mixed evidence for osteoarthritis symptom relief; no healthspan evidence.
Safety
Score:
2.5
Justification:
Generally well-tolerated with low incidence of minor side effects.
Flags
- May interact with anticoagulants like warfarin, increasing bleeding risk.
- Efficacy for joint pain is inconsistent across studies.
- Individuals with shellfish allergies should use glucosamine cautiously.
Verdict
Targeted joint support for osteoarthritis symptoms; no direct healthspan impact.